Tumor angiogenesis: molecular pathology, therapeutic targeting, and imaging.
about
High and low frequency subharmonic imaging of angiogenesis in a murine breast cancer modelThe antiangiogenic effects of a vascular endothelial growth factor decoy receptor can be monitored in vivo using contrast-enhanced ultrasound imaging.Comparing contrast-enhanced color flow imaging and pathological measures of breast lesion vascularity.Perfusion CT for the assessment of tumour vascularity: which protocol?Estimation of radiation exposure of 128-slice 4D-perfusion CT for the assessment of tumor vascularity.Assessment of acute antivascular effects of vandetanib with high-resolution dynamic contrast-enhanced computed tomographic imaging in a human colon tumor xenograft model in the nude ratBlood vessels are regulators of growth, diagnostic markers and therapeutic targets in prostate cancer.Contrast enhanced maximum intensity projection ultrasound imaging for assessing angiogenesis in murine glioma and breast tumor models: A comparative study.Dynamic contrast-enhanced MRI in clinical oncology: current status and future directions.New targeted molecular therapies for cancer: radiological response in intrathoracic malignancies and cardiopulmonary toxicity: what the radiologist needs to knowPulmonary nodule characterization: a comparison of conventional with quantitative and visual semi-quantitative analyses using contrast enhancement mapsPerfusion CT: a worthwhile enhancement?Tumor angiogenesis as a target for dietary cancer preventionThe assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations.Tumour angiogenesis: the relevance to surgeons.Prediction of prostate cancer extracapsular extension with high spatial resolution dynamic contrast-enhanced 3-T MRI.Perfusion computed tomography in colorectal cancer: protocols, clinical applications and emerging trends.Synergistic chemopreventive effects of nobiletin and atorvastatin on colon carcinogenesis.Monitoring angiogenesis in human melanoma xenograft model using contrast-enhanced ultrasound imaging.Ultrasound contrast-enhanced study as an imaging biomarker for anti-cancer drug treatment: preliminary study with paclitaxel in a xenograft mouse tumor model (secondary publication).Phase II trial of thalidomide in renal-cell carcinoma.Contrast-enhanced ultrasonography for assessment of tumor vascularity in hepatocellular carcinoma.Comparing Quantitative Immunohistochemical Markers of Angiogenesis to Contrast-Enhanced Subharmonic Imaging.B1 transmission-field inhomogeneity and enhancement ratio errors in dynamic contrast-enhanced MRI (DCE-MRI) of the breast at 3T.Predictive factors of response to treatment in patients with metastatic renal cell carcinoma: new evidence.Combination therapy of radiofrequency ablation and bevacizumab monitored with power Doppler ultrasound in a murine model of hepatocellular carcinoma
P2860
Q30375548-CC496033-A5BD-46AA-A78F-D7EF418AE776Q30409780-07D5F7DA-C701-400A-B567-1ADE90A724A1Q33330783-E0EF78B6-C3EE-4286-B343-8EC4CEA4EFB8Q33981942-05AAAC10-024E-4B39-A4A1-807EDA5C3E71Q34092033-BCA3BF8D-91EB-4568-A50C-65D5968B935CQ34105344-EDFFC885-0150-44A5-B944-D57D320C9DE1Q34534087-253F7E2B-E078-48D9-AC01-86B137D3DBA4Q34536116-A7EB96A2-907E-40A9-9C88-78B0E378DD86Q34918635-F2B7DE62-F320-4145-9C87-EEF1EC6E81F7Q35093270-EA59872C-4C35-45B3-A28D-9F293D220028Q35103773-D11580B6-CB70-460D-A75D-9522209AF443Q35113503-72B81328-DEB4-41D6-9A1A-0DC440C0613EQ35250910-E195AC5D-B71F-4BC0-AA3D-89334096ED61Q36616812-1764DED8-A558-44B2-8216-24BBD7E79685Q36632396-7722C167-ED61-4781-B036-CDCAD6B0D2B0Q36792155-C344A6E5-80E4-4C17-9005-CE5BC589A091Q37550249-92BFF7B0-F7A4-414E-8694-F76F5D7B4312Q38716191-2073AE1D-320E-4E67-9D5E-A55D909CA9CAQ39840949-2EB74F21-C386-4D2B-A213-D75D13A61AD0Q42367599-C2E5C855-47BF-4490-A076-261D9D0214A7Q44101920-7A56546E-AB51-42DF-9645-92EA49294492Q48909870-E4E1C87D-0EB0-41C7-A709-9B94E39DC00FQ50879371-3A173BB2-968C-4280-8A08-F4BEFC4A3F92Q51765007-6FC740F4-8588-43F5-8E81-6E24DF5B7926Q54578801-89D97F57-B77E-439B-AC32-3E67785FC49BQ57317511-8AF08EFB-C3FD-4659-8A25-36C28D80D117
P2860
Tumor angiogenesis: molecular pathology, therapeutic targeting, and imaging.
description
2000 nî lūn-bûn
@nan
2000 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Tumor angiogenesis: molecular pathology, therapeutic targeting, and imaging.
@ast
Tumor angiogenesis: molecular pathology, therapeutic targeting, and imaging.
@en
Tumor angiogenesis: molecular pathology, therapeutic targeting, and imaging.
@nl
type
label
Tumor angiogenesis: molecular pathology, therapeutic targeting, and imaging.
@ast
Tumor angiogenesis: molecular pathology, therapeutic targeting, and imaging.
@en
Tumor angiogenesis: molecular pathology, therapeutic targeting, and imaging.
@nl
prefLabel
Tumor angiogenesis: molecular pathology, therapeutic targeting, and imaging.
@ast
Tumor angiogenesis: molecular pathology, therapeutic targeting, and imaging.
@en
Tumor angiogenesis: molecular pathology, therapeutic targeting, and imaging.
@nl
P1433
P1476
Tumor angiogenesis: molecular pathology, therapeutic targeting, and imaging.
@en
P2093
P304
P356
10.1016/S1076-6332(00)80629-7
P577
2000-10-01T00:00:00Z